(Q36132185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

review article

1 reference

title

Current trends in neuropathic pain treatments with special reference to fibromyalgia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

0 references

0 references

Martin Offenbaecher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

Manfred Ackenheil

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

page(s)

285-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

Clinical characteristics and economic costs of patients with painful neuropathic disorders

12 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Anticonvulsants in neuropathic pain: rationale and clinical evidence

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

https://api.crossref.org/works/10.1017%2FS1092852900022616

1 reference

7 January 2021

A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

A pilot study of the beneficial effects of amantadine in the treatment of painful diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Efficacy of intravenous magnesium in neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Psychological aspects of neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Advances in the management of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Tramadol induces antidepressant-type effects in mice

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Modulation of synaptic plasticity by stress and antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

The prevalence and characteristics of fibromyalgia in the general population.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Translation of symptoms and signs into mechanisms in neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Neuropathic pain and injured nerve: central mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Pharmacologic treatment of pain in polyneuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Mechanistic Stratification of Antineuralgic Agents

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Pain phenomena and possible mechanisms in patients with painful polyneuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Towards a mechanism-based classification of pain?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Evidence for abnormal pain processing in fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Diagnosis and Treatment of Neuropathic Pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Rational and targeted pharmacologic treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Effects of duloxetine on painful physical symptoms associated with depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Difficulties in stratifying neuropathic pain by mechanisms

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Effects of IV morphine in central pain: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Oral opioid therapy for chronic peripheral and central neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Lamotrigine in spinal cord injury pain: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

Analgesic effect of dextromethorphan in neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

The clinical picture of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900022616

7 January 2021

10.1017/S1092852900022616

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15902759%20AND%20SRC:MED&resulttype=core&format=json

12 January 2020

1 reference